Open Access Open Access  Restricted Access Subscription or Fee Access

Fixing a broken drug development process

John Holland

Abstract


It costs about $1.2 billion to bring a single new drug to market in the U.S. today.[1] With a combination of high late-stage failure rates and the high cost of drug trials, the number of new drugs being approved by the FDA has flat-lined at historically low levels, falling from 53 in 1996 to just 19 in 2009.[2] If the cost of drug trials doesn’t come down, we will see far fewer new drugs on pharmacy shelves.


[1] Pharmaceutical Research and Manufacturers of America Profile 2009. Washington, DC: PhRMA.

[2] Hughes B. 2009 Drug Approvals. Nature Reviews Drug Discovery 9, 89-92 (February 2010)


Keywords


telehealth; telemonitoring; remote healthcare technologies; remote patient monitoring

Full Text:

PDF


DOI: http://dx.doi.org/10.5912/jcb588

Refbacks

  • There are currently no refbacks.




Copyright © thinkBiotech LLC